Viewing StudyNCT06321341

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06321341
Status: RECRUITING
Last Update Posted: 2024-03-20
First Post: 2024-03-13
Brief Title: Efficacy and Safety of Vespireit Sustained-release Tablets in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo
Sponsor: Valenta Pharm JSC
Organization: Valenta Pharm JSC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Vertigo
Autonomic Dysfunction
Keywords: